Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies
Yuchen Qu, Yunli Yu, Jie Pan, Haiyan Li, Cheng Cui, Dongyang Liu
Topics & Concepts
MedicineFebuxostatHyperuricemiaUric acidBenzbromaronePharmacologyXanthine oxidasePharmacokineticsPharmacodynamicsAllopurinolInternal medicineBiochemistryEnzymeChemistryGout, Hyperuricemia, Uric AcidThyroid Disorders and TreatmentsKidney Stones and Urolithiasis Treatments